CytoDyn Inc. Names Dr. Nader Pourhassan New CEO; Announces New Chief Scientific Officer Sep 11, 2012 5:52pm EDT
CytoDyn Announces Entry into Agreement with Progenics Pharmaceuticals, Inc. to Acquire PRO 140 Jul 30, 2012 2:01pm EDT
